VACCINE effectivenessVACCINESThis article discusses a recent study on the immune responses to COVID-19 vaccination among patients with rheumatoid arthritis. The study found that patients on immunosuppressive therapies may have weaker immune responses to the vaccine, which could lead to more severe...
1, Apurv Shah1, Nutcha Wattanchit1, Martha W. Zorn1, Nicholas G. Reich1 ✉ & US COVID-19 Forecast Hub Consortium* Academic researchers, government agencies, industry groups, and individuals have produced forecasts at an unprecedented scale during the COVID-19 ...
What's the purpose of this article? A. To tell American adults they can get a COVID-19 vaccine. B. To inform that American children can't get a COVID-19 vaccine. C. To give information about clinical trials of vaccines in teens and kids. D. To provide information for potential ...
A clinical trial evaluating the safety and effectiveness of a nasal vaccine candidate known as MPV/S-2P to protect against COVID-19 recently began
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public health burden worldwide. In addition to respiratory, heart, and gastrointestinal symptoms,
The government said it plans to stop using Moderna's monovalent Covid-19 vaccine from next month."The expiration date of the currently introduced Moderna's monovalent vaccine is Dec. 16, and we plan to stop using the vaccine in consideration of the publi
low availability of PPE kits for healthcare workers and the general fear of the pandemic. This meant that countries suddenly face the threat of COVID-19 along with the threat of outbreaks of vaccine-preventable diseases and deaths. Such disruptions can have a ruinous impact on child mortality....
Special Issue on COVID-19 – Vaccine, Variants and New Waves Edited byProf Rehab H. El-Sokkary Last update October 2021 First Thematic Issue on Novel Coronavirus (COVID-19) Edited by Dr. Sameera Al Johani Dr. Shuaib Hussain Last update June 2020 ...
February 27, 2021. The EUA was later revised and limited its use to people 18 years and above who are unable to access the approved COVID-19 vaccines or those choosing to receive the Ad26.COV2.S vaccination. The fourth vaccination to receive EUA was the NVX-CoV2373 vaccine on July 13...
NEW ARTICLE: IVERMECTIN and CANCER Part 2 - Treating Turbo Cancer - 7 new studies released in 2024 show Ivermectin works against CANCER - suggested PROTOCOLS for COVID-19 mRNA Vaccine Induced Turbo CancersLast year, in October, I wrote one of the most popular articles on Ivermectin (IVM) and...